2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

Bibliographic Details
Title: 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Authors: Rodríguez-Carrio, J., Burska, A., Conaghan, P. G., Dik, W. A., Biesen, R., Eloranta, M.-L., Cavalli, G., Visser, M., Boumpas, D. T., Bertsias, G.
Source: Annals of the rheumatic diseases. 82(6):754-762
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632210267&indx=1&recIds=ETOCRN632210267
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:00034967
Published in:Annals of the rheumatic diseases
Language:English